Lawrence Alleva
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lawrence Alleva
Earlier roles on record: Board Member at Galera Therapeutics, Inc. (GRTXD) until August 3, 2026. Galera Therapeutics, Inc. reported in an 8-K filed August 4, 2026 that Lawrence Alleva resigned as Board, effective August 3, 2026.
“In accordance with the Merger Agreement, immediately prior to the closing of the Mergers, J. Mel. Sorensen, Michael Friedman, Nancy Chang, Lawrence Alleva and Kevin Lokay resigned from the Board and committees of the Board on which they respectively served, which resignations were not the result of any disagreements with the Company relating to its operations, policies or practices.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2019-01-01–2026-08-03
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.